Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 62.1 TWD 0.81% Market Closed
Market Cap: 11.1B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Interest Income Expense
NT$47.1m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
10%
Y
YungShin Global Holding Corp
TWSE:3705
Interest Income Expense
NT$237.9m
CAGR 3-Years
217%
CAGR 5-Years
53%
CAGR 10-Years
13%
Formosa Laboratories Inc
TWSE:4746
Interest Income Expense
-NT$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ScinoPharm Taiwan Ltd
TWSE:1789
Interest Income Expense
NT$45.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
S
SCI Pharmtech Inc
TWSE:4119
Interest Income Expense
-NT$17.3m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lotus Pharmaceutical Co Ltd
TWSE:1795
Interest Income Expense
NT$224.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Standard Chem & Pharm Co Ltd
Glance View

Market Cap
11.1B TWD
Industry
Pharmaceuticals

Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.

Intrinsic Value
96.87 TWD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Standard Chem & Pharm Co Ltd's Interest Income Expense?
Interest Income Expense
47.1m TWD

Based on the financial report for Sep 30, 2024, Standard Chem & Pharm Co Ltd's Interest Income Expense amounts to 47.1m TWD.

What is Standard Chem & Pharm Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
10%

Over the last year, the Interest Income Expense growth was -57%.

Back to Top